State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors.

Eric P Tamm, Priya Bhosale, Jeffrey H Lee, Eric M Rohren

Journal: Surgical oncology clinics of North America 2016;25(2):375-400

PMID: 27013371

Abstract

Pancreatic neuroendocrine tumors are rare tumors that present many imaging challenges, from detecting small functional tumors to fully staging large nonfunctioning tumors, including identifying all sites of metastatic disease, particularly nodal and hepatic, and depicting vascular involvement. The correct choice of imaging modality requires knowledge of the tumor type (eg, gastrinoma versus insulinoma), and also the histology (well vs poorly differentiated). Evolving techniques in computed tomography (CT), MRI, endoscopic ultrasonography, and nuclear medicine, such as dual-energy CT, diffusion-weighted MRI, liver-specific magnetic resonance contrast agents, and new nuclear medicine agents, offer new ways to visualize, and ultimately manage, these tumors.

Copyright © 2016 Elsevier Inc. All rights reserved.

Address: Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Unit 1473, PO Box 301402, Houston, TX 77230-1402, USA. Electronic address: [email protected].; Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Unit 1473, PO Box 301402, Houston, TX 77230-1402, USA.; Department of Gastroenterology, Hepatology and Nutrition, T. Boone Pickens Academic Tower (FCT13.6028), 1515 Holcombe Boulevard, Unit 1466, Houston, TX 77030, USA.; Department of Nuclear Medicine, T. Boone Pickens Academic Tower (FCT16.6012), 1515 Holcombe Boulevard, Unit 1483, Houston, TX 77030, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.